/
/
Save the Date – IMMUPARKNET Final Annual Conference 2026 in Coimbra

Save the Date – IMMUPARKNET Final Annual Conference 2026 in Coimbra

We are pleased to announce that the fourth and final Annual Conference of the IMMUPARKNET Action will take place in Coimbra, Portugal, from 12 to 14 June 2026.

The conference will be hosted at the Faculty of Medicine of the University of Coimbra (FMUC), part of one of the oldest and most prestigious universities in Europe.

This final annual meeting will include:

  • Action updates
  • All Working Group meetings
  • Oral and Poster presentations of latest works
  • Management Committee meeting
  • Stakeholders interactions
  • Additional scientific and networking activities

Participation and Eligibility

Please note that any researcher, not only ImmuParkNet Working Group members, may apply to attend the conference and be reimbursed, subject to the availability of reimbursements.

To be eligible, researchers must:

  • Be affiliated with an IMMUPARKNET member institution, or
  • Join the Action before applying.

Registration and Invitations

  • General registration will open in February 2026.
  • All invitations are personal and not transferable.
  • Full details on the programme, registration and reimbursement procedures will be released soon.

We look forward to welcoming you in Coimbra for the final ImmuParkNet Annual Conference.

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

Latest Updates

wpc2026_logo

IMMUPARKNET, the leading network dedicated to researching the role of immunity and neuroinflammation in Parkinson’s Disease, proudly announces the participation of its prominent members at...

IMG_1591

For more than 20 years, the Dopamine Meetings have provided a collaborative forum for scientists from diverse backgrounds to share their latest work and ideas....

ChatGPT Image 27 mag 2026, 10_24_30

📍 Faculty of Medicine, University of Coimbra (FMUC), Portugal📅 12–14 June 2026 We are pleased to present the final program of the 4th and final...

Seville, 9–10 April 2026 The second edition of the IMMUPARKNET Training School was held at the Instituto de Biomedicina de Sevilla (IBiS) in Seville, Spain,...

Article wordpress

A new study published in “The Lancet Neurology” investigates whether azathioprine, a common immunosuppressant, could represent a breakthrough in slowing the progression of Parkinson’s Disease...

328ec109-a3d1-4ef6-84fd-795b242d1f3d

We are pleased to announce that the call for grant applications for Grant Period 4 of ImmuParkNet is now open. This call covers activities to...